Europe's leading Prefilled Syringes event is coming to the USA in 2014

1. 4, London
20
TH RE
RE
A D GI
G
N EC ST
I
D
20 STE
SA EM ER B
14 R
V BE Y
A BY
N 28 E $ R 2
D
SA TH 300 013
VE FEB
$1 RUA
00 RY
P-114_5__ 21/11/2013 11:59 Page 3
“A wise choice of location and an intelligently designed program of expert
speakers promises to bring together the leading minds and influencers mapping
the future of the prefilled syringes sector.”
Guy Furness, Proprietor & Publisher, ONdrugDelivery Magazine
SMi present the 8th conference and exhibition in its world leading series...
Floor
0BS, UK
erence price
rence price
VAILABLE
Fee
$2398.00
$1799.00
$599.00
Pre-Filled Syringes
Americas
Development, manufacture and regulation of
pre-filled syringe and injector devices
Renaissance Woodbridge Hotel, Iselin, New Jersey, USA
$1598.00
$999.00
$599.00
31ST MARCH
- 1ST APRIL
2014
KEY SPEAKERS INCLUDE:
• Scott Brown, Device Development Lead, Merck
• Alexei Goraltchouk, Senior Manager, Operations, Regeneron
• Stephen Barat, Senior Director, Toxicology and Operations, Forest
Laboratories
• Steven Projan, SVP, MedImmune*
• Martin Dearden, Chief Corporate Microbiologist, UCB
• Thomas Osterberg, Senior Manager, Biologics, Pfizer Inc
• Greg Sacha, Senior Research Scientist, Baxter
• Christian Siegmund, Head of Prefilled Syringes and liquid vials, Roche
• Ravi S. Harapanhalli, Vice President, ParExel, and Former FDA
Senior Executive
£1198.80
access
tions,
Total
WHY ATTEND THIS EVENT:
• 3 days of presentations, panel discussions and interactive
workshops. Return to your business with the information and
contacts to make the right decisions for your products
• Focus sessions on biologics, manufacturing, polymers and
extractables and leachables
• 20+ expert speakers from throughout the PFS and device ecosystem
• 85+ key decision makers, influencers and innovation drivers
attending from the most relevant and sought after organisations in
pre-filled syringes
• Network with delegates from the leading Biotechnology and
Pharmaceutical businesses globally during the series of networking
breaks, lunches and networking evenings designed to help
conversation flow
• Hands on exhibition to help you evaluate the leading solutions in the
marketplace and meet the thought leaders who developed them
£598.80
£499.00
, by one of
e. Bookings
of payment
2R 8AU
*stc
□□
PLUS AN INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOP
EX card
Accelerating the regulatory approval of your pre-filled product:
Insight into combination product approvals
tomers and
here
____________
ne.co.uk
Wednesday 2nd April 2014, Iselin, New Jersey, USA
Workshop Leaders: Ravi S. Harapanhalli, Vice President, ParExel, and Former FDA Senior Executive, and Mr. Sall, Principal Consultant, ParExel
8.30am - 12.30pm
Sponsored by
www.pfsamericas.com
REGISTER BY 20TH DECEMBER 2013 AND SAVE $300 / REGISTER BY 28TH FEBRUARY 2014 AND SAVE $100
Register online or call +448709090711 to speak to an account executive

2. P-114_5__ 21/11/2013 11:59 Page 4
Pre-Filled Syringes Americas
www.pfsamericas.
Day One | Monday 31st March 2014
8.30
Registration & Coffee
2.00
9.00
Chairman's Opening Remarks
Alexei Goraltchouk, Senior Manager, Operations Regeneron
Introduction to Medical grade Cyclo Olefin Polymers (COP)
• Key properties of current Medical grade Cycloolefin polymer
(COP)
• Regulatory Status
• Bio-Compatibility and Protein Adsorption study
9.10
9.50
10.40
KEYNOTE ADDRESS: Avoiding the pitfalls of device development
• What to look out for when developing your delivery device
• The 5 reasons product fail
• How can you plan to mitigate the risk of product failures
Scott Brown, Device Development Lead, Merck
• Effect of Gamma/EB/Steam sterilization
• Introduction of new product
Toshiro Katayama, Product Manager, Zeon Chemicals
2.40
products
HEADLINE PANEL: Developments in pre filled
syringes and injection devices
PANEL
• What are key aspects driving the exponential
growth of the market?
• Which challenges need to be worked out to continue
expansion?
• What’s next for pre filled syringes, where will the growth come
from?
Steven Projan, SVP, MedImmune (STC)
Lloyd Fishman, President, High Peaks Partners LLC
Michael Dudley, CEO, Artemes Technologies
Moderator: Cliff Mintz, Associate Editor, Life Science Leader
Morning refreshments and networking in the exhibition area
DEVELOPING YOUR COMBINATION PRODUCTS OR INJECTABLE DEVICE
Panel: Developing delivery systems for biological
• Overcoming viscosity and needle size challenges
PANEL
• How can you ensure E&L are within acceptable
limits?
• Seeking efficient FDA approval for RA and other drug products
• When should you develop your own solution and when should
you work with a partner?
Dr Thomas Osterberg, Senior Manager, Biologics, Pfizer
Martin Dearden, Corporate Microbiologist, UCB
William Lambert, Fellow, Drug Delivery and Device
Development, MedImmune
Moderator: Cliff Mintz, Associate Editor, Life Science Leader
3.30
Afternoon refreshments and networking in the exhibition area
4.00
Pre-filled syringe manufacturing, a review of processes and
challenges
11.10
11.50
12.30
Foreign Particulate Matter and Siliconization Testing
• rap.ID and Foreign Particulate Matter Identification
• Siliconization Process – Spray on vs. Emulsion
• Silicone Control Methods – Historical and Actual
• Layer Explorer – Technology and Case Studies
Oliver Valet, President, rap.ID
Next generation Pre-Filled Syringes: How are electronic auto
injectors changing the market?
• Trends in electronic injectors and how they compare to
pre-filled syringes
• What are the key procurement challenges that category
managers will face
• How these differ from conventional Pre Filled Syringe
challenges
Chanderkanth Gautam, Senior Research Analyst, Beroe Inc
Geetha Vaithyanathan, Domain Lead, Beroe Inc
Networking Lunch held in the exhibition area
• New challenges with COP and COC containers
• How to effectively reduce particle contamination
• When’s the right time in product development to decide on
delivery systems?
Greg Sacha, Senior Research Scientist, Baxter
4.40
Cutting edge developments in pre filled syringe design soon to
be ready for testing
• How are advances in syringe design going to open the market
for new applications in PFS
• Developments in 2 chamber syringes capable of mixing
powders and liquids
• Advances in large polymer syringes with the capacity to
administer of nutritional gels
Michael Spigarelli, Professor of Internal Medicine, Pediatrics and
Pharmacy, University of Utah School of Medicine
5.20
Chairman's Closing Remarks and Close of Day One
Register online at: www.pfsamericas.com • Alternatively fax your registr
Official Platinum Media Partner
Sponsored by
rap.ID Particle Systems GmbH
rap.ID Particle Systems provides compliant solutions for the control of silicone and other lubricants
thickness and distribution in pre-filled syringes. rap.ID also offers contract testing services
providing particles identification and root cause analysis. rap.IDs good particle ID equipment
reveals enumeration as well as the chemical structure and elements of microparticles. This
becoming a standard in the identification of foreign particulate matter with a unique speed and
power of distinction. www.rap-id.com
Zeon Europe GmbH
Achieve glass-like transparency and excellent long-term stability with protein- and peptidebased drugs by using ZEONEX®. ZEONEX® cyclo-oleflin polymers, break-resistant plastics
designed for critical pharmaceutical packaging applications including vials, pre-filled syringes,
and blister packaging. ZEONEX® COP is an ultra-clean plastic that does not contain additives or
components that leach-out over time. Additionally, for protein-based drugs, common proteins
show low adsorption onto ZEONEX containers as compared to other plastics. For more
information, visit www.zeonex.com or email zeonex@zeonchemicals.com
Official Leading Media Partner

3. P-114_5__ 21/11/2013 11:59 Page 5
Pre-Filled Syringes Americas
HALF-DA
W
Day Two | Tuesday 1st April 2014
Renaissanc
.pfsamericas.com
(COP)
8.30
Registration & Coffee
12.00
Networking Lunch held in the exhibition area
polymer
OVERCOMING MANUFACTURING CHALLENGES
OF PRE-FILLED SYRINGES AND INJECTOR DEVICES
REGULATORY SESSIONS: HOW YOU CAN ENSURE EFFICIENT APPROVAL
9.00
Chairman's Opening Remarks
Ravi S. Harapanhalli, Vice President, ParExel, former FDA Senior
1.30
Cambridge Judge Business School
s
• New drugs that require large injections: Why are bolus injectors
Managing the safety assessment of leachables for pre-filled
are required?
syringe drug products
volume injections
leachables.
development
assessment of leachables
• Example devices and their properties– Unilife, BD, West, Ratio,
• How to approach the qualification of leachables and
hen should
SteadyMed etc.
considerations needed during development and life-cycle
Tom Oakley, Director of Drug Delivery Device Development,
management.
Springboard
• Working examples to illustrate approach and key principles.
Stephen Barat, Senior Director, Toxicology and Operations, Forest
2.10
Laboratories
Case Study: Benefits and challenges of pre-filled syringe isolator
filling machines
• Latest updates on how to overcome challenges
9.40
Getting to market: Regulatory perspective
• Minimization of product errors and scratches
• Defining a pre-filled syringe as a product or device and its
on area
• Overcoming the challenges of machine start ups
impact on regulatory approval
• Methods of inspection: Visual and automated machines
• Roadmap to approval for PFS’s and auto injectors
Christian Siegmund, Head of Prefilled Syringes and liquid vials,
• Insight into the FDA’s current thoughts
s and
Executive
2.50
Afternoon refreshments and networking in the exhibition area
Programme
9.00
Reg
9.30
10.10
Morning refreshments and networking in the exhibition area
3.20
Developing your fill and finish production lines
Intro
9.45
Ses
dev
Ses
• Upcoming trends in fill and finish functionality
Considerations to gain international regulatory approval
• Adhering to visual inspection guidelines
10.30
• Considerations to make when developing your manufacturing
10.40
n soon to
• Considerations for international export markets
11.00
Cof
Martin Dearden, Chief Corporate Microbiologist, UCB
11.30
Ses
reg
Future trends in the pre filled syringes and medical devices
12.00
Ses
thro
12.30
End
facility
• Overcoming the challenges of the Japanese market?
the market
• Planning for success in multiple regions
4.00
Brij Patel, CEO, RegExcel
xing
atrics and
Why you sh
• Accelera
delivery s
• Find out h
product g
• Assess the
drug deliv
• Develop
managem
• Understan
Regulatio
• Know how
delivery d
• Get to ap
device d
• Perform r
assessme
Roche
Ravi S. Harapanhalli, Vice President, ParExel, former FDA Senior
ecide on
ty to
Workshop o
Run by one
approval p
Ravi Harap
help you p
help with a
delays in ta
• Why a new class of device, the bolus injector, is under
• The use of scientifically-justified threshold levels in the safety
g products
ader
• The limitations of autoinjectors and infusion pumps for large
• Current trends in the safety assessment of extractables and
PANEL
Ravi S.
Mr.
The market and technologies for large volume (‘bolus’) injections
• Findings from study conducted in conjunction with the
Executive
9.10
Acceler
your p
com
• Delivery technology, business and operational needs from the
How should you manage your biological assessment of medical
• Usability, user preference, and learning from patient feedback
devices
• The next generation of needs, as opposed to the next
drug-makers perspective
11.20
• Safety evaluations of E&L
About the w
generation technology
• Adhering to regulations in the EU and beyond
Alexei Goraltchouk, Senior Manager, Operations Regeneron
• Benefits and pit falls of different container materials
Adam Wooley, CEO, ForthTox
4.40
Chairman’s Closing Remarks and Close of Day Two
About the w
y fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711
Supported by
About ParE
Over the
significant e
pharmace
device ind
of their pro
treatments
who need
Massachus
throughout
and has ov

4. P-114_5__ 21/11/2013 12:00 Page 6
HALF-DAY POST-CONFERENCE WORKSHOP
Wednesday 2nd April 2014
8.30am - 12.30pm
Renaissance Woodbridge, Iselin, New Jersey, USA
Accelerating the regulatory approval of
your pre-filled product : Insight into
combination product approvals
Workshop Leaders:
Ravi S. Harapanhalli, Vice President, ParExel
Mr. Sall, Principal Consultant, ParExel
) injections
e
s injectors
r large
Workshop overview:
Run by one of the US’s leading figures in regulatory
approval processes and drug delivery systems, Dr.
Ravi Harapanhalli. This industry leading workshop will
help you plan for smooth regulatory approvals and
help with avoiding pitfalls that can cause expensive
delays in taking your product to market.
er
st, Ratio,
ment,
ge isolator
nes
d vials,
n area
Why you should attend:
• Accelerate the time it takes to take your drug
delivery system to market
• Find out how to navigate new combination
product guidelines
• Assess the right time to start thinking about your
drug delivery mechanism
• Develop a strategy for product life cycle
management by switching over to PFS
• Understand how to apply the FDA Quality System
Regulation to delivery device development
• Know how to apply FDA Design Controls to
delivery device development
• Get to appreciate how to selection of a delivery
device development partner
• Perform risk analysis and Human Factors
assessment
Programme
9.00
Registration
9.30
Introductions and Opening Remarks
9.45
Session 1: Quality-by-Design in the
development of drug delivery systems
10.30
Session 2: Regulatory pit falls to avoid
11.00
vices
Coffee break
11.30
Session 3: New combination product
regulations and how to comply with them
12.00
Session 4: How to accelerate approval
through FDA
12.30
End of Workshop
from the
feedback
xt
neron
About the workshop host
Dr.
Ravi
Harapanhalli
advises
bio/pharmaceutical companies on
CMC regulatory strategies and Qualityby-Design approaches to medicinal
product development and flexible
regulatory approaches.
About the workshop co-leader
Mr. Sall is a Principal Consultant with
PAREXEL Consulting in Waltham, MA.
PAREXEL provides clinical trial, clinical
data management, medical and regulatory services to the pharmaceutical
and medical device industries.
About ParExel
Over the past 30 years, ParExel has developed
significant expertise to assist clients in the worldwide
pharmaceutical, biotechnology and medical
device industries with the development and launch
of their products in order to bring safe and effective
treatments to the global marketplace for the patients
who need them. Headquartered near Boston,
Massachusetts, ParExel operates over 77 locations
throughout more than 51 countries around the world,
and has over 14,400 employees.

5. P-114_5__ 21/11/2013 11:58 Page 1
SPONSORSHIP AND
EXHIBITION OPPORTUNITIES
Conferenc
Imagine a room full of the highest
level decision-makers from your
target market...
SMi offer sponsorship, advertising and
branding packages, uniquely tailored to
compliment your company's marketing
strategy. Prime networking opportunities
exist to entertain, enhance and expand
your client base within the context of an
independent discussion specific to your
industry.
Expected audience at
Pre-Filled Syringes Americas:
Audience by Location
■
■
North America
Europe
■
■
Asia
Rest of World
Audience by Sector
■
■
Bio Tech
/Pharma
Pre-Filled
Systems
■
■
Pre-Filled
Components
Product
Equipment
SPONSORSHIP ENQUIRIES
Should you wish to join the increasing number
of companies benefiting from sponsoring our
conferences please call:
Alia Malick, Director on +44 (0) 20 7827 6168 or
email: amalick@smi-online.co.uk
Want to know how you can get involved?
Interested in promoting your services
to this market?
Contact Julia Rotar, SMi Marketing on
+44 (0) 207 827 6088, or
email: jrotar@smi-online.co.uk
If you

6. d
nents
ent
PRE-FILLED SYRINGES AMERICAS
Workshop: Wednesday 2nd April 2014, London
4 WAYS TO REGISTER
FAX your booking form to +44 (0) 870 9090 712
PHONE on +44 (0) 870 9090 711
POST your booking form to: Events Team, SMi Group Ltd, 2nd Floor
South, Harling House, 47-51 Great Suffolk Street, London, SE1 0BS, UK
EARLY BIRD □
DISCOUNT □
Book by 20th December to receive a $300 discount off the conference price
Book by 28th February to receive a $100 discount off the conference price
CONFERENCE PRICES
Unique Reference Number
Our Reference
LV P-114
DELEGATE DETAILS
Please complete fully and clearly in capital letters. Please photocopy for additional delegates.
Title:
Forename:
Surname:
Job Title:
Department/Division:
Company/Organisation:
G
www.pfsamericas.com
RE
Conference: Monday 31st March & Tuesday 1st April 2014, Renaissance Woodbridge Hotel, Iselin, New Jersey, USA
20
TH RE
A D GI
N EC ST
I
D
20 STE
S EM ER
14 R
BY AV BE BY
A
N 28 E $ R 2
D
P-114_5__ 21/11/2013 11:58 Page 2
GROUP DISCOUNTS AVAILABLE
I would like to attend: (Please tick as appropriate)
□ Conference & Workshop
□ Conference Only
□ Workshop Only
Pharmaceutical Companies Rates: LIMITED AVAILABILITY
□ Conference & Workshop
□ Conference Only
□ Workshop Only
PROMOTIONAL LITERATURE DISTRIBUTION
□ Distribution of your company’s promotional
literature to all conference attendees
£999.00 + VAT
Fee
$2398.00
$1799.00
$599.00
$1598.00
$999.00
$599.00
£1198.80
Email:
The conference fee includes refreshments, lunch, conference papers and access
Company VAT Number:
to the Document Portal containing all of the presentations.
Address:
DOCUMENTATION
Town/City:
Post/Zip Code:
Country:
Direct Tel:
Direct Fax:
Unable to travel, but would like to watch the conference live, ask questions,
participate as if you were in the room.
Price
Total
Mobile:
□ Access to the conference documentation
Switchboard:
Signature:
Date:
I agree to be bound by SMi's Terms and Conditions of Booking.
ACCOUNTS DEPT
Title:
on the Document Portal
£499.00 + VAT
£499.00 (or only £300 if ordered with the Document Portal)
□ The Conference Presentations - paper copy
£598.80
£499.00
Forename:
Surname:
PAYMENT
Email:
Address (if different from above):
Payment must be made to SMi Group Ltd, and received before the event, by one of
the following methods quoting reference P-114 and the delegate’s name. Bookings
made within 7 days of the event require payment on booking, methods of payment
are below. Please indicate method of payment:
Town/City:
Post/Zip Code:
Country:
Direct Tel:
Direct Fax:
VENUE Renaissance Woodbridge Hotel, 515 U.S. Route 1, Iselin, NJ 08830
□ Please contact me to book my hotel
Alternatively call us on +44 (0) 870 9090 711,
email: hotels@smi-online.co.uk or fax +44 (0) 870 9090 712
Terms and Conditions of Booking
Payment: If payment is not made at the time of booking, then an invoice will be issued and must be
paid immediately and prior to the start of the event. If payment has not been received then credit
card details will be requested and payment taken before entry to the event. Bookings within 7 days
of event require payment on booking. Access to the Document Portal will not be given until payment
has been received.
Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another
delegate to take your place at any time prior to the start of the event. Two or more delegates may
not ‘share’ a place at an event. Please make separate bookings for each delegate.
Cancellation: If you wish to cancel your attendance at an event and you are unable to send a
substitute, then we will refund/credit 50% of the due fee less a £50 administration charge, providing
that cancellation is made in writing and received at least 28 days prior to the start of the event.
Regretfully cancellation after this time cannot be accepted. We will however provide the
conferences documentation via the Document Portal to any delegate who has paid but is unable
to attend for any reason. Due to the interactive nature of the Briefings we are not normally able to
provide documentation in these circumstances. We cannot accept cancellations of orders placed
for Documentation or the Document Portal as these are reproduced specifically to order. If we have
to cancel the event for any reason, then we will make a full refund immediately, but disclaim any
further liability.
Alterations: It may become necessary for us to make alterations to the content, speakers, timing,
venue or date of the event compared to the advertised programme.
Data Protection: The SMi Group gathers personal data in accordance with the UK Data Protection
Act 1998 and we may use this to contact you by telephone, fax, post or email to tell you about other
products and services. Unless you tick here □ we may also share your data with third parties offering
complementary products or services. If you have any queries or want to update any of the data that
we hold then please contact our Database Manager databasemanager@smi-online.co.uk or visit
our website www.smi-online.co.uk/updates quoting the URN as detailed above your address on the
attached letter.
A/C Name SMI GROUP LTD Sort Code 300009,
Account Number 11775391 CCY USD
□ Wire Transfer Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AU
IBAN GB75LOYD30000911775391
BIC LOYDGB21013
□ Cheque
We can only accept cheques in US Dollars.
□ Credit Card □ Visa □ MasterCard □ American Express
All credit card payments will be subject to standard credit card charges.
□□□□ □□□□ □□□□ □□□□
Valid From □□/□□ Expiry Date □□/□□
CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card
Card No:
Cardholder’s Name:
Signature:
Workshop L
Date:
I agree to be bound by SMi's Terms and Conditions of Booking.
Card Billing Address (If different from above):
VAT
VAT at 20% is charged on Document Portal and literature distribution for all UK customers and
for those EU Customers not supplying a registration number for their own country here
______________________________________________________________________________________________
If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email them at events@smi-online.co.uk
REGISTE